Bristol-Myers Squibb, uniQure to Develop Gene Therapies

The collaboration includes uniQure’s proprietary gene therapy program for congestive heart failure that is intended to restore the heart’s ability to synthesize S100A1
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news